For the Inventor, By the Inventor

Enter assignee name

Birmingham, AL, United States of America

Southern Research Institute

USPTO Granted Patents = 203

CIPO Patents = 5

EPO Patents = 25

Trademarks = 4

Forward Citations = 4,890

Loading Chart...

Loading Chart...

256 inventors (with patents filed for the assignee):

John A Montgomery (32 out of 60 patents)

John A Secrist, Iii (30 out of 39 patents)

Subramaniam Ananthan (25 out of 25 patents)

4. Mark J Suto (21 out of 34 patents)

5. Thomas R Tice (18 out of 49 patents)

6. Corinne E Augelli-Szafran (18 out of 18 patents)

7. Joseph A Maddry (14 out of 15 patents)

8. Bini Mathew (12 out of 13 patents)

9. Ashish Kumar Pathak (12 out of 12 patents)

10. Carroll G Temple, Jr (12 out of 15 patents)

11. Jay K Staas (10 out of 16 patents)

12. Robert C Reynolds (10 out of 10 patents)

13. Richard M Gilley (10 out of 12 patents)

14. Kamal N Tiwari (9 out of 10 patents)

15. Y Fulmer Shealy (9 out of 11 patents)

Core Competencies:

Uracil Derivatives

Nucleoside Phosphorylase Prodrugs

RNA-binding Protein Inhibitors

Cancer Therapy

Programmed Death-ligand Modulators

Neurodegenerative Disease Treatments

Antiviral Agents

Kidney Disease Compounds

TGF-beta Inhibitors

Thermoelectric Power Generation

Porous Materials

Mixed Metal Oxide Catalysts

203 patents: Sort by Forward Citations

1. 12486254 - Uracil derivatives for stimulating read-through of premature termination codons (2025-12-02),

2. 12453760 - Enhanced therapeutic usage of a purine nucleoside phosphorylase or nuceloside hydrolase prodrug (2025-10-28),

3. 12435091 - RNA-binding protein multimerization inhibitors and methods of use thereof (2025-10-07),

4. 12215108 - Development of potential antidotes for arsenicals (2025-02-04),

5. 12208112 - Composition for treating blood cancer using 4'-thio-5-Aza-2′-deoxycytidine and uses thereof (2025-01-28),

6. 12103943 - Development of novel clofarabine analogs for cancer therapy (2024-10-01),

7. 12098216 - Modulators of programmed death-ligand-1 and/or programmed death-ligand-2 (2024-09-24),

8. 11945781 - Compounds for the treatment of acute and chronic kidney disease (2024-04-02),

9. 11932626 - 2-pyrimidone analogs as potent antiviral agents against Alphaviruses (2024-03-19),

10. 11905306 - Substituted phenyl ethynyl pyridine carboxamides as potent inhibitors of SARS virus (2024-02-20),

11. 11905258 - 2-aminoaryl-5-aryloxazole analogs for the treatment of neurodegenerative diseases (2024-02-20),

12. 11858956 - 6-aza-nucleoside prodrugs as antiviral agents for treating virus infections (2024-01-02),

13. 11752153 - Substituted quinazoline sulfonamides as thioredoxin interacting protein (TXNIP) inhibitors (2023-09-12),

14. 11718593 - 2,5-aryl-thiazole analogs for the treatment of neurodegenerative diseases (2023-08-08),

15. 11623918 - Compounds for the treatment of acute and chronic kidney disease (2023-04-11),

Southern Research Institute is a not-for-profit research organization that offers contract research services, discovery and development of innovative technologies, and conducts preclinical research for various industries including aerospace, energy, and biotechnology.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

203 Patents

#2 in Birmingham, AL

#5 in Alabama

#1,964 in US

#4,049 in the World

Birmingham, AL, United States of America

Southern Research Institute

Forward Citations = 4,890

256 inventors:

John A Montgomery (32 out of 60 patents)

John A Secrist, Iii (30 out of 39 patents)

Subramaniam Ananthan (25 out of 25 patents)

4. Mark J Suto (21 out of 34 patents)

5. Thomas R Tice (18 out of 49 patents)

Please report any incorrect information to support@idiyas.com

Loading…